Dr. Robert Hamilton, MD

NPI: 1154367837
Total Payments
$13,131
2024 Payments
$57.33
Companies
77
Transactions
870
Medicare Patients
834
Medicare Billing
$132,627

Payment Breakdown by Category

Food & Beverage$13,131 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,131 870 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $1,476 115 $0 (2022)
Genentech USA, Inc. $1,132 53 $0 (2022)
Merck Sharp & Dohme LLC $1,072 80 $0 (2023)
Amgen Inc. $909.91 61 $0 (2022)
Celgene Corporation $894.76 35 $0 (2023)
Novartis Pharmaceuticals Corporation $801.49 68 $0 (2022)
Janssen Biotech, Inc. $747.62 76 $0 (2023)
PFIZER INC. $592.94 52 $0 (2023)
Astellas Pharma US Inc $539.98 28 $0 (2023)
Incyte Corporation $495.93 28 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $57.33 2 Exelixis Inc. ($31.03)
2023 $516.17 27 Janssen Biotech, Inc. ($74.55)
2022 $963.58 55 E.R. Squibb & Sons, L.L.C. ($192.96)
2021 $1,287 74 Celgene Corporation ($268.10)
2020 $505.75 32 Astellas Pharma US Inc ($41.41)
2019 $2,876 212 Merck Sharp & Dohme Corporation ($439.08)
2018 $3,278 225 E.R. Squibb & Sons, L.L.C. ($488.99)
2017 $3,648 243 Genentech USA, Inc. ($391.40)

All Payment Transactions

870 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
08/30/2024 ABBVIE INC. EPKINLY (Drug), IMBRUVICA Food and Beverage In-kind items and services $26.30 General
Category: ONCOLOGY
05/21/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $31.03 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
12/05/2023 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $23.92 General
Category: ONCOLOGY
10/13/2023 Takeda Pharmaceuticals U.S.A., Inc. ICLUSIG (Drug) Food and Beverage In-kind items and services $18.33 General
Category: ONCOLOGY
09/25/2023 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI Food and Beverage In-kind items and services $19.37 General
Category: Oncology
09/21/2023 Takeda Pharmaceuticals U.S.A., Inc. ICLUSIG (Drug) Food and Beverage In-kind items and services $20.20 General
Category: ONCOLOGY
06/27/2023 EMD Serono, Inc. BAVENCIO (Drug) Food and Beverage Cash or cash equivalent $16.42 General
Category: Oncology
06/21/2023 Astellas Pharma US Inc Xospata (Drug) Food and Beverage In-kind items and services $28.64 General
Category: Oncology
06/14/2023 Seagen Inc. ADCETRIS (Biological) Food and Beverage In-kind items and services $14.52 General
Category: Oncology
06/13/2023 GENZYME CORPORATION JEVTANA (Drug) Food and Beverage In-kind items and services $16.83 General
Category: Oncology
06/05/2023 MorphoSys, US Inc. MONJUVI (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Oncology
05/23/2023 G1 Therapeutics, Inc. COSELA (Drug) Food and Beverage Cash or cash equivalent $21.27 General
Category: ONCOLOGY
05/17/2023 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $20.55 General
Category: Hematology
05/10/2023 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $14.96 General
Category: Oncology
04/28/2023 Incyte Corporation MONJUVI (Drug) Food and Beverage Cash or cash equivalent $20.39 General
Category: Oncology
04/05/2023 Kite Pharma, Inc. Food and Beverage In-kind items and services $17.34 General
03/31/2023 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI Food and Beverage In-kind items and services $15.04 General
Category: Oncology
03/30/2023 Puma Biotechnology, Inc. Food and Beverage In-kind items and services $15.99 General
03/21/2023 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG, LYNPARZA Food and Beverage In-kind items and services $18.54 General
Category: ONCOLOGY
03/14/2023 GENZYME CORPORATION JEVTANA (Drug) Food and Beverage In-kind items and services $20.06 General
Category: Oncology
03/07/2023 EMD Serono, Inc. BAVENCIO (Drug) Food and Beverage Cash or cash equivalent $14.23 General
Category: Oncology
03/01/2023 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $24.95 General
Category: Oncology
02/23/2023 PFIZER INC. XTANDI (Drug), ORGOVYX, COMIRNATY Food and Beverage In-kind items and services $16.09 General
Category: ONCOLOGY
02/14/2023 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI Food and Beverage In-kind items and services $15.19 General
Category: Oncology
02/10/2023 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $17.65 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 91 217 $56,427 $14,820
2022 7 175 439 $96,872 $29,326
2021 7 260 647 $124,530 $46,223
2020 8 308 667 $131,058 $42,258
Total Patients
834
Total Services
1,970
Medicare Billing
$132,627
Procedure Codes
27

All Medicare Procedures & Services

27 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 19 65 $23,920 $6,314 26.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 20 73 $14,089 $4,240 30.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 23 39 $6,591 $1,603 24.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 29 $7,163 $1,473 20.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 11 11 $4,664 $1,190 25.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 28 98 $31,262 $9,839 31.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 30 167 $27,990 $8,761 31.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 39 71 $15,657 $4,084 26.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 18 18 $8,291 $2,560 30.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 27 52 $7,556 $2,332 30.9%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 20 20 $3,450 $1,056 30.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 13 13 $2,666 $694.39 26.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 37 150 $40,500 $15,895 39.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 60 251 $37,650 $13,530 35.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 55 99 $12,375 $4,917 39.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 27 31 $12,555 $4,713 37.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 34 67 $13,400 $4,447 33.2%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 33 35 $5,250 $1,903 36.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 14 14 $2,800 $816.32 29.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 33 142 $38,340 $11,540 30.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 65 207 $31,050 $11,442 36.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 55 104 $20,800 $5,736 27.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 32 34 $13,770 $5,193 37.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 47 95 $11,875 $3,218 27.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 47 56 $8,400 $3,060 36.4%

About Dr. Robert Hamilton, MD

Dr. Robert Hamilton, MD is a Medical Oncology healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154367837.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hamilton, MD has received a total of $13,131 in payments from pharmaceutical and medical device companies, with $57.33 received in 2024. These payments were reported across 870 transactions from 77 companies. The most common payment nature is "Food and Beverage" ($13,131).

As a Medicare-enrolled provider, Hamilton has provided services to 834 Medicare beneficiaries, totaling 1,970 services with total Medicare billing of $132,627. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.

Practice Information

  • Specialty Medical Oncology
  • Location Jackson, MS
  • Active Since 06/21/2006
  • Last Updated 04/09/2014
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1154367837

Products in Payments

  • OPDIVO (Biological) $1,178
  • KEYTRUDA (Biological) $958.20
  • TECENTRIQ (Biological) $711.27
  • Revlimid (Drug) $520.15
  • IMBRUVICA (Drug) $373.58
  • GILOTRIF (Drug) $334.21
  • JAKAFI (Drug) $301.55
  • DARZALEX (Biological) $287.09
  • XTANDI (Drug) $282.60
  • Nplate (Biological) $270.83
  • Avastin (Biological) $231.55
  • IBRANCE (Drug) $216.59
  • CFN PleurX (Device) $209.77
  • AFINITOR (Drug) $193.32
  • Cabometyx (Drug) $179.64
  • KISQALI (Drug) $174.04
  • ELITEK (Drug) $170.28
  • Neulasta (Biological) $160.95
  • Pomalyst (Drug) $149.63
  • Xtandi (Drug) $134.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Jackson